Does a medical oncology perform her2-targeted therapy?

They decide which HER2-directed medicine to use, whether to combine it with another treatment and what monitoring is needed before and during therapy.

HER2 is a protein that can help some cancer cells grow. A sample of the tumour is tested, and the oncologist interprets the result alongside the cancer type, its extent and previous treatment.

HER2-targeted medicines may be given through a vein, by injection or as tablets, depending on the drug. Some are used with chemotherapy or other systemic medicines. Monitoring can include symptom reviews, blood tests and checks of heart function.

Bring details of previous cancer treatment, heart problems, regular medicines and allergies. Complete the requested baseline tests, and tell the service promptly if you develop an infection or new breathing symptoms before an appointment.

Keep to the treatment and monitoring schedule, take oral medicines exactly as instructed and check before starting supplements. Record diarrhoea, rash, fatigue, swelling or shortness of breath so the oncology team can assess patterns and offer support.

Seek prompt oncology advice for new or worsening breathlessness, swelling of the legs, a rapid weight increase, persistent cough, severe diarrhoea, fever, chills or signs of infection. These symptoms can require examination and changes to the treatment plan.

During an infusion, report flushing, rash, dizziness, chest tightness or breathing difficulty immediately. Call emergency services for severe breathing problems, chest pain, collapse or swelling of the face or throat.

Ask what your HER2 result means, which medicine is recommended, why it suits your situation and whether it will be combined with chemotherapy, hormone therapy or another treatment.

Check how the medicine is given, which heart and blood tests are planned, what side effects warrant a same-day call and how treatment will be adjusted if problems develop.